Retrorubral Field (A8) Dopaminergic Neurons

Retrorubral Field (A8) Dopaminergic Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Retrorubral Field (A8) Dopaminergic Neurons</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">TH</td>
<td>High</td>
</tr>
<tr>
<td class="label">DDC</td>
<td>High</td>
</tr>
<tr>
<td class="label">SLC6A3</td>
<td>High</td>
</tr>
<tr>
<td class="label">SLC18A2</td>
<td>High</td>
</tr>
<tr>
<td class="label">CALB1</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">CALB2</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">RGS9</td>
<td>Moderate</td>
</tr>
</table>

Retrorubral Field (A8) Dopaminergic Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Retrorubral Field (A8) Dopaminergic Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Retrorubral Field (A8) Dopaminergic Neurons</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">TH</td>
<td>High</td>
</tr>
<tr>
<td class="label">DDC</td>
<td>High</td>
</tr>
<tr>
<td class="label">SLC6A3</td>
<td>High</td>
</tr>
<tr>
<td class="label">SLC18A2</td>
<td>High</td>
</tr>
<tr>
<td class="label">CALB1</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">CALB2</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">RGS9</td>
<td>Moderate</td>
</tr>
</table>

Retrorubral Field (A8) Dopaminergic Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

The Retrorubral Field (RRF), also known as the A8 dopaminergic cell group, is a midbrain region located caudal to the substantia nigra pars compacta. It contains dopaminergic [neurons](/entities/neurons) that project to various brain regions and play important roles in motor control, reward processing, and cognitive functions. The RRF is affected in [Parkinson's disease](/diseases/parkinsons-disease) and may contribute to non-motor symptoms. [@german1996]

Morphology and Markers

The Retrorubral Field contains heterogeneous neuronal populations: [@hornykiewicz1998]

• Dopaminergic neurons: Express tyrosine hydroxylase (TH) and aromatic L-amino acid decarboxylase (AADC)
• GABAergic interneurons: Express GAD67 and parvalbumin
• Glutamatergic neurons: Express vesicular glutamate transporters
• Mixed neurochemistry: Many RRF neurons co-release dopamine and GABA

Brain Region: Midbrain, retrorubral area, near the cerebral peduncle [@ciliax1995]

Cell Group Designation: A8 (according to Dahlström and Fuxe classification) [@haber1995]

Projections: [@janzen2012]

• Prefrontal [cortex](/brain-regions/cortex)
• Anterior cingulate cortex
• [Amygdala](/brain-regions/amygdala)
• Lateral septum
• [Hypothalamus](/brain-regions/hypothalamus)

Normal Function

The Retrorubral Field serves several important functions: [@francois1999]

Vulnerability in Disease

Parkinson's Disease

• Dopaminergic neuron loss: RRF neurons undergo degeneration in PD, though less severe than SNc
• Non-motor symptoms: RRF dysfunction may contribute to depression, anxiety, and cognitive impairment in PD
• Levodopa response: RRF neurons may have different pharmacological responses compared to SNc
• Therapeutic implications: Understanding RRF may help explain variable treatment responses and develop better therapies

Alzheimer's Disease

• Dopaminergic alterations: RRF may show neurotransmitter changes in AD
• Cognitive dysfunction: Frontal cortical projections may contribute to executive deficits in AD
• Mood symptoms: Dopaminergic dysregulation may contribute to depression in AD

Other Neurodegenerative Diseases

• Progressive Supranuclear Palsy (PSP): RRF involvement may contribute to frontal symptoms
• Multiple System Atrophy (MSA): Dopaminergic system dysfunction includes RRF
• Frontotemporal Dementia (FTD): Frontal projections may be affected

Transcriptomic Profile

Key genes expressed in retrorubral field neurons:

Allen Brain Atlas Reference: Retrorubral field gene expression data available at [Allen Mouse Brain Atlas](https://mouse.brain-map.org/).

Therapeutic Implications

Current Approaches

• Dopamine replacement therapy: Levodopa affects RRF neurons
• Dopamine agonists: May have different effects on RRF vs SNc

Emerging Therapies

• Cell replacement therapy: RRF neurons as potential targets
• Gene therapy: Targeting dopamine synthesis in RRF
• Neuroprotective strategies: Protecting RRF neurons from degeneration

Research Directions

• Understanding selective vulnerability of RRF neurons
• Developing RRF-specific treatments
• Biomarkers for RRF dysfunction in neurodegeneration

Background

The study of Retrorubral Field (A8) Dopaminergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [Allen Brain Atlas: Retrorubral Field](https://mouse.brain-map.org/)
• [Michael J. Fox Foundation for Parkinson's Research](https://www.michaeljfox.org/)
• [Parkinson's Foundation](https://www.parkinson.org/)

See Also

• [Neurodegeneration](/wiki/diseases-neurodegeneration) — cell_type_involved_in